Carl Decicco is CSO at Foghorn Therapeutics Inc. (FHTX). They have made 1 open-market trade across 1 company since 2020, most recently 2021-12-09.
CIK 0001828727
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $88K since 2020, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| FHTX | 362,707 | $675K |
Shares reported on the most recent Form 4, priced at the 2021-12-13 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FHTX | BUY | 2020-10-27 | 2020-10-29 | $16.00 | $88K | -1.9% | +22.8% | +6.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.